Trial NCT03971734

View at ClinicalTrials.gov 
Org. Study IDs: ABTC 1804
Secondary IDs: UM1CA137443

Last trial update was posted on 2023-10-06

MeSH Interventions

Regadenoson

MeSH Conditions

Astrocytoma Glioblastoma Glioma Oligodendroglioma

Other Conditions

Anaplastic Astrocytoma Anaplastic Oligodendroglioma High Grade Glioma

Stopping Reasons

Terminated [NCI decided to terminate ABTC Consortium due to NCI moving in different direction for Brain Cancer]

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID